| [1] Grigsby B，Rodriguez-Rilo H，Khan K. Antioxidants and chronic pancreatitis： theory of oxidative stress and trials of antioxidant therapy[J]. Dig Dis Sci，2012，57 (4)：835-841. [2] Cho HY，Reddy SP，Kleeberger SR. Nrf2 defends the lung from oxidative stress[J]. Antioxid Redox Signal，2006，8 (1/2)：76-87. [3] Magesh S，Chen Y，Hu LQ. Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents[J]. Med Res Rev，2012，32 (4)：687-726. [4] Kang MI，Kobayashi A，Wakabayashi N，et al. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes[J]．Proc Natl Acad Sci，2004，101 (7)： 2046-2051． [5] Jain AK，Mahajan S，Jaiswal AK. Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2：A novel mechanism in Nrf2 activation[J]. J Bio Chem，2008，283 (5)：17712-17720. [6] Dreger H，Westphal K，Weller A，et al. Nrf2-dependent upregulation of antioxidative enzymes：a novel pathway for proteasome inhibitor-mediated cardioprotection[J]. Cardiovasc Res，2009，83 (2)：354-361. [7] Tkachev VO，Menshchikova EB，Zenkov NK. Mechanism of the Nrf2/Keap1/ARE signaling system[J]. Biochemistry：Mosc，2011，76 (4)：407-422. [8] Hu R，Saw CL，Yu R，et al. Regulation of Nrf2 signaling for cancer chemoprevention：antioxidant coupled with anti-inflammatory[J]. Antioxid Redox Signal，2010，13 (11)：1679-1698. [9] Baird L，Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway[J]. Arch Toxicol ，2011，85 (4)：241-272. [10] Sun Z，Zhang S，Chan JY，et al. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2[J]. Mol Cel Biol ，2007，27 (18)：6334-6349. [11] Kaspar JW，Jaiswal AK. An autoregulatory loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance[J]. J Biol Chem， 2010，285 (28)：21349-21358. [12] Lebovitz RM，Zhang H，Vogel H，et al. Neurodegeneration， myocardial injury，and perinatal death in mitochondrial superoxide dismutase-deficient mice[J]. Proc Natl Acad Sci USA，1996，93 (18)：9782-9787. [13] Yen HC，Oberley TD，Gairola CG，et al. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice[J]. Arch Biochem Biophys， 1999， 362 (1)：59-66. [14] Na HK，Kim EH，Jung JH，et al. (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells[J]. Arch Biochem Biophys， 2008，476 (2)：171-177. [15] Zhang R，Chae S，Lee JH，et al. The cytoprotective effect of butin against oxidative stress is mediated by the up-regulation of manganese superoxide dismutase expression through a PI3K/Akt/Nrf2-dependent pathway[J]. J Cell Biochem，2012，113 (6)：1987-1997. [16] Gebicki JM，Nauser T，Domazou A，et al. Reduction of protein radicals by GSH and ascorbate：potential biological significance[J]. Amino Acids，2010，39 (5)：1131-1137. [17] Banki K，Hutter E，Colombo E，et al. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression[J]. J Biol Chem，1996，271 (51)：32994-3001. [18] Harvey CJ，Thimmulappa RK，Singh A，et al. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress[J]. Free Radic Biol Med，2009，46 (4)：443-453. [19] Li J，Jin J，Li M，et al. Role of Nrf2 in protection against triptolide-induced toxicity in rat kidney cells[J]. Toxicol Lett，2012，213 (2)： 194-202. [20] Ma W，Yuan L，Yu H，et al. Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by beta-amyloid peptides 25-35 in PC12 cells[J]. Int J Dev Neurosci，2010，28 (4)：289-295. [21] Ji L，Liu R，Zhang XD，et al. N-acetylcysteine attenuates phosgene-induced acute lung injury via up-regulation of Nrf2 expression[J]. Inhal Toxicol，2010，22 (7)：535-542. [22] Haines DD，Lekli I，Teissier P，et al. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies：focus on cardiovascular， lung，neurological and kidney disorders[J]. Acta Physiol (Oxf)，2012， 204 (4)：487-501. [23] Kim KC，Kang KA，Zhang R，et al. Up-regulation of Nrf2-mediated heme oxygenase-1 expression by eckol，a phlorotannin compound， through activation of Erk and PI3K/Akt[J]. Int J Biochem Cell Biol，2010，42 (2)：297-305. [24] Lee SE，Jeong SI，Yang H，et al. Extract of Salvia miltiorrhiza (Danshen) induces Nrf2-mediated heme oxygenase-1 expression as a cytoprotective action in RAW 264.7 macrophages[J]. J Ethnopharmacol， 2012，139 (2)：541-548. [25] Nioi P，Hayes JD. Contribution of NAD (P)H：quinone oxidoreductase 1 to protection against carcinogenesis，and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors[J]. Mutat Res，2004，555 (1/2)： 149-171. [26] Xiao H，Lv F，Xu W，et al. Deprenyl prevents MPP (+)-induced oxidative damage in PC12 cells by the upregulation of Nrf2-mediated NQO1 expression through the activation of PI3K/Akt and Erk[J]. Toxicology， 2011，290 (2/3)：286-294. [27] Ungvari Z，Bailey-Downs L，Gautam T，et al. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia[J]. Am J Physiol Heart Circ Physiol， 2011， 300 (4)：1133-1140. [28] Han SG，Han SS，Toborek M，et al. EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes[J]. Toxicol Appl Pharmacol，2012， 261 (2)：181-188. [29] Halliwell B. Antioxidants in human health and disease[J]. Annu Rev Nutr，1996，16 (1)：33-50. [30] Ramos-Gomez M，Kwak MK，Dolan PM，et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor-deficient mice[J]. Proc Natl Acad Sci USA，2001，98 (6)：3410-3415. [31] Kwak MK，Kensler TW. Targeting NRF2 signaling for cancer chemoprevention[J]. Toxicol Appl Pharmacol，2010，244 (1)：66-76. [32] Kensler TW，Wakabayashi N，Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway[J]. Annu Rev Pharmacol Toxicol，2007，47 (1)：89-116. [33] Marhenke S，Lamle J，Buitrago-Molina LE，et al. Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development[J]. Hepatology，2008，48 (2)：487-496. [34] Thimmulappa RK，Mai KH，Srisuma S，et al. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray[J]. Cancer Res，2002，62 (18)：5196- 5203. [35] Emerit J，Edeas M，Bricaire F. Neurodegenerative diseases and oxidative stress[J]. Biomed Pharmacother，2004，58 (1)：39-46. [36] Poon HF，Calabrese V，Scapagnini G，et al. Free radicals：key to brain aging and heme oxygenase as a cellular response to oxidative stress[J]. J Gerontol A Biol Sci Med Sci ，2004，59 (5)：478-493. [37] Jazwa A，Rojo AI，Innamorato NG，et al. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism[J]. Antioxid Redox Signal，2011，14 (12)：2347-2360. [38] Burton NC，Kensler TW，Guilarte TR. In vivo modulation of the Parkinsonian phenotype by Nrf2[J]. Neurotoxicology，2006，27 (6)： 1094-1100. [39] van Muiswinkel FL，Kuiperij HB. The Nrf2-ARE signalling pathway： Promising drug target to combat oxidative stress in neurodegenerative disorders[J]. Curr Drug Targets CNS Neurol Disord，2005，4 (3)：267-281. [40] Abdul-Ghani MA，Jani R，Chavez A，et al. Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants[J]. Diabetologia，2009，52 (4)：574-582. [41] Aleksunes LM，Reisman SA，Yeager RL，et al. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice[J]. J Pharmacol Exp Ther，2010，333 (1)：140-151. [42] Cheng XH，Siow RCM，Mann GE. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes：a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway[J]. Antioxid Redox Sign，2011，14 (3)：469-487. [43] He XQ，Kan H，Cai L，et al. Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes[J]. J Mol Cell Cardiol，2009，46 (1)：47-58. |
